Verici Dx (LSE:VRCI) Dividends per Share : £0.00 (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Verici Dx Dividends per Share?

Verici Dx's dividends per share for the six months ended in Jun. 2023 was £0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2023 was 0.00. As of today, Verici Dx's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Verici Dx Dividends per Share Historical Data

The historical data trend for Verici Dx's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Dividends per Share Chart

Verici Dx Annual Data

Trend

Dec20

Dec21

Dec22

Dividends per Share

Verici Dx Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23
Dividends per Share	-	-	-	-	-

Competitive Comparison of Verici Dx's Dividends per Share

For the Diagnostics & Research subindustry, Verici Dx's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verici Dx's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Verici Dx's Dividend Yield % falls into.

Verici Dx Dividends per Share Calculation

Dividends paid to per common share.

Verici Dx (LSE:VRCI) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Verici Dx's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	0	/	-0.025
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Verici Dx Dividends per Share Related Terms

Thank you for viewing the detailed overview of Verici Dx's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Verici Dx (LSE:VRCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (LSE:VRCI) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

VRCDF:USA

Address

19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ

Website

https://www.vericidx.com

Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, that of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx (LSE:VRCI) Headlines

No Headlines